关于儿科药物启动的见解:护理人员和儿童的看法
Maria Rubio-Valera1,2,3,4, Cristina Carbonell-Duacastella1,3, Maite Peñarrubia-María3,5,6
1Health Technology Assessment in Primary Care and Mental Health (PRISMA) Research Group, Teaching, Research and Innovation Unit, Institut de Recerca Sant Joan de Déu, de Llobregat, Spain.
护理人员对疾病和药物风险的看法,以及医疗保健系统因素,影响儿科药物启动. 涉及儿童和支持护理人员的共同决策可以改善治疗坚持.
科学领域:
- 儿科药理学 儿科药理学
- 健康决策的决策过程
- 定性研究是一种定性研究.
背景情况:
- 对于儿童来说,处方药的很大一部分并未开始使用.
- 了解非启动背后的动机对于改善儿科治疗坚持至关重要.
研究的目的:
- 探索影响儿童开始药物治疗的决定因素.
- 从护理人员和儿童的角度了解这些因素.
主要方法:
- 采用有基础的理论与建设主义方法的定性研究.
- 在西班牙 (2021-2022) 与21名护理人员和6名儿童进行了半结构面试.
- 药剂师,儿科医生和家庭医生对转录的采访进行了持续的比较分析.
主要成果:
- 护理人员 (主要是母亲) 是治疗启动决策的核心,很少涉及儿童.
- 决策是基于受疾病/药物,人内因素,儿童相关因素,专业互动,医疗保健系统信任和情境影响 (例如媒体,耻辱) 的感知影响的风险效益评估.
- 医疗保健专业人员的可访问性,沟通,尊重和支持显著影响护理人员的决策.
结论:
- 儿科药物启动是多因素的,涉及感知,人内,人际,医疗保健系统和上下文因素.
- 共享决策,包括儿童的意见和照顾护理人员的支持需求,对于促进治疗启动至关重要.
更多相关视频
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
相关概念视频
Factors Affecting Drug Response: Overview
Drug Therapy
Antianxiety Medications
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
